ASCO | Professor Dickon Hayne Shares ANZUP 1301 Findings: Combined Mitomycin Intravesical Therapy May Help Alleviate BCG Shortage in High-Risk NMIBC
Editor’s note: Bacillus Calmette–Guérin (BCG) is the standard intravesical therapy for patients with high-risk non–muscle-invasive bladder cancer (NMIBC). However, in some countries and regions, BCG shortages remain a challenge, limiting…
